Screen every patient for financial toxicity at diagnosis and refer like any other symptom
Ask about money problems with a short validated questionnaire when treatment starts, and route those at risk to financial navigators before bills cause missed doses.
Financial toxicity is associated with non-adherence, bankruptcy and worse survival, and is invisible unless asked about. The COST-FACIT instrument is validated and short. The proposal is universal screening at diagnosis and at each treatment change, with automatic referral to financial navigation (benefits, assistance programmes, employment rights, billing review), and inclusion of the score as a routinely collected outcome in registries and trials.
- Patients lack understanding, navigation and agency · Most patients cannot understand their options, find trials, or push back, so decisions are made for them.
- Prices and value · New cancer drugs routinely cost over $150,000 a year, often for months of benefit. Systems cannot afford them and patients go bankrupt.
Pages like this
not linked directly; found by shared links- IdeaScreen every patient for financial hardship at diagnosis and connect them to help
Shares Patients lack understanding, navigation and agency, Prices and value.
- InstitutionNational Comprehensive Cancer Network (NCCN)
Shares Patients lack understanding, navigation and agency, Prices and value.
- Key paperPrasad: most surrogate endpoints in cancer trials correlate poorly with survival
Shares Patients lack understanding, navigation and agency, Prices and value.
- CollectionNCCN Guidelines
Shares Patients lack understanding, navigation and agency, Prices and value.